Allergan, Inc. : AGN

All AGN Articles

189 Articles

Paul Ausick | Dec 18, 2014 at 12:00 PM EST

9 Big Stocks That Doubled in 2014

Here is a look at the top performers for 2014, nine stocks that have doubled and have a current market…

Jon C. Ogg | Nov 18, 2014 at 8:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Alcoa, EA, Intel, IBM, Sony, Tyco, Wells Fargo and More

This Tuesday's top analyst upgrades, downgrades and initiations include AK Steel, Alcoa, Electronic Arts, Intel, IBM, Sony, Tyco International and…

Paul Ausick | Nov 17, 2014 at 10:05 AM EST

Allergan Accepts Buyout Offer From Actavis, Valeant Bows Out

Botox maker Allergan has entered a definitive agreement to be acquired by Actavis, despite higher offer from Valeant Pharmaceuticals.

Paul Ausick | Oct 24, 2014 at 10:05 AM EDT

What Does ValueAct See in Taking an Activist Role in Fertilizers?

Hedge fund ValueAct Capital Management has disclosed acquisition of 5.7% stake in Agrium.

Jon C. Ogg | Oct 9, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Gap, Intel, J.C. Penney, Kinder Morgan and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. on Thursday, October 9, 2014.

Jon C. Ogg | Oct 1, 2014 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Boeing, eBay, Hecla Mining, Janus Capital, Orbitz, Ford and More

These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Wednesday, October 1, 2014.

Lee Jackson | Sep 29, 2014 at 8:30 AM EDT

3 Likely Biotech Buyout Candidates

A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could…

Jon C. Ogg | Sep 23, 2014 at 1:30 PM EDT

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have…

Jon C. Ogg | Aug 8, 2014 at 8:34 AM EDT

Top Analyst Upgrades and Downgrades: Zynga, Barrick, Allergan, BioCryst, Mylan, NVIDIA and More

Jon OggStocks turned green on Friday morning on hopes out of Russia, but the markets have remained at risk. Now…

Jon C. Ogg | Jul 22, 2014 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 22, 2014. They include…

Paul Ausick | Jul 21, 2014 at 9:45 AM EDT

Allergan Chops 1,500 Jobs to Fend Off Valeant

Allergan reported better-than-expected second-quarter 2014 results before markets opened Monday morning. The Botox-maker also announced that it will execute a…

Paul Ausick | Jul 21, 2014 at 8:30 AM EDT

Valeant Offer Weaker After Allergan Earnings

In a sharply worded press release Monday morning, Valeant Pharmaceuticals said that it "can no longer tolerate" statements from Allergan…

Jon C. Ogg | Jul 16, 2014 at 5:44 PM EDT

John Paulson Talks Up Valeant and Allergan, and Merger Arb

ThinkstockHedge fund manager John Paulson spoke at the CNBC Institutional Investor Delivering Alpha conference on Wednesday, offering keen insight in…

Jon C. Ogg | Jul 1, 2014 at 7:20 AM EDT

Top Gainers of the S&P 500 of 2014 and the Second Quarter

24/7 Wall St. wanted to take a look at the best and worst stocks of the DJIA and the S&P…

Trey Thoelcke | Jun 17, 2014 at 9:05 AM EDT

UBS New Stocks to Buy for Growth at a Reasonable Price

ThinkstockIf there was ever a time to get an update on one of the top lists of stocks to buy…

1 … 6 7 8 9 10 … 13

Allergan, Inc. : AGN

All AGN Articles

9 Big Stocks That Doubled in 2014

Top Analyst Upgrades and Downgrades: AK Steel, Alcoa, EA, Intel, IBM, Sony, Tyco, Wells Fargo and More

Allergan Accepts Buyout Offer From Actavis, Valeant Bows Out

What Does ValueAct See in Taking an Activist Role in Fertilizers?

Top Analyst Upgrades and Downgrades: Apple, Gap, Intel, J.C. Penney, Kinder Morgan and More

Top Analyst Upgrades and Downgrades: Boeing, eBay, Hecla Mining, Janus Capital, Orbitz, Ford and More

3 Likely Biotech Buyout Candidates

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

Top Analyst Upgrades and Downgrades: Zynga, Barrick, Allergan, BioCryst, Mylan, NVIDIA and More

Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More

Allergan Chops 1,500 Jobs to Fend Off Valeant

Valeant Offer Weaker After Allergan Earnings

John Paulson Talks Up Valeant and Allergan, and Merger Arb

Top Gainers of the S&P 500 of 2014 and the Second Quarter

UBS New Stocks to Buy for Growth at a Reasonable Price

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Allergan, Inc. : AGN

All AGN Articles

9 Big Stocks That Doubled in 2014

Top Analyst Upgrades and Downgrades: AK Steel, Alcoa, EA, Intel, IBM, Sony, Tyco, Wells Fargo and More

Allergan Accepts Buyout Offer From Actavis, Valeant Bows Out

What Does ValueAct See in Taking an Activist Role in Fertilizers?

Top Analyst Upgrades and Downgrades: Apple, Gap, Intel, J.C. Penney, Kinder Morgan and More

Top Analyst Upgrades and Downgrades: Boeing, eBay, Hecla Mining, Janus Capital, Orbitz, Ford and More

3 Likely Biotech Buyout Candidates

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

Top Analyst Upgrades and Downgrades: Zynga, Barrick, Allergan, BioCryst, Mylan, NVIDIA and More

Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More

Allergan Chops 1,500 Jobs to Fend Off Valeant

Valeant Offer Weaker After Allergan Earnings

John Paulson Talks Up Valeant and Allergan, and Merger Arb

Top Gainers of the S&P 500 of 2014 and the Second Quarter

UBS New Stocks to Buy for Growth at a Reasonable Price

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It